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Abstract
Background: Delay in seeking care is a major impediment to effective management of tuberculosis (TB) in China.
To elucidate factors that underpin patient and diagnostic delays in TB management, we conducted a systematic
review and meta-analysis of factors that are associated with delays in TB care-seeking and diagnosis in the country.
Methods: This review was prepared following standard procedures of the Cochrane Collaboration and the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement and checklist. Relevant studies
published up to November 2012 were identified from three major international and Chinese literature databases:
Medline/PubMed, EMBASE and CNKI (China National Knowledge Infrastructure).
Results: We included 29 studies involving 38,947 patients from 17 provinces in China. Qualitative analysis showed
that key individual level determinants of delays included socio-demographic and economic factors, mostly poverty,
rural residence, lack of health insurance, lower educational attainment, stigma and poor knowledge of TB. Health
facility determinants included limited availability of resources to perform prompt diagnosis, lack of qualified health
workers and geographical barriers.
Quantitative meta-analysis indicated that living in rural areas was a risk factor for patient delays (pooled odds ratio
(OR) (95% confidence interval (CI)): 1.79 (1.62, 1.98)) and diagnostic delays (pooled OR (95% CI): 1.40 (1.23, 1.59)).
Female patients had higher risk of patient delay (pooled OR (95% CI): 1.94 (1.13, 3.33)). Low educational attainment
(primary school and below) was also a risk factor for patient delay (pooled OR (95% CI): 2.14 (1.03, 4.47)). The
practice of seeking care first from Traditional Chinese Medicine (TMC) providers was also identified as a risk factor
for diagnostic delay (pooled OR (95% CI): 5.75 (3.03, 10.94)).
Conclusion: Patient and diagnostic delays in TB care are mediated by individual and health facility factors.
Population-based interventions that seek to reduce TB stigma and raise awareness about the benefits of early diagnosis
and prompt treatment are needed. Policies that remove patients’ financial barriers in access to TB care, and integration
of the informal care sector into TB control in urban and rural settings are central factors in TB control.
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Background
Although progress has been made in global tuberculosis
(TB) control [1], the disease remains one of the most in-
tractable health challenges in low- and middle-income
countries. Globally, TB remains the second leading cause
of death from infectious diseases (after HIV/AIDS) [1].
Over the past five years, there has been a marked
increase in the number of TB patients diagnosed with
multi-drug resistant TB (MDR-TB) [1]. China has the
world’s second largest tuberculosis epidemic and has
contributed significantly to this MDR-TB increase. Re-
sults of the 5th National TB Survey in China in 2010
showed an estimated 8.28 million cases of pulmonary
TB (PTB) in the country from 2001 to 2010 [2]. In spite
of concerted international and national efforts to address
TB in the country, annual prevalence (per 100,000
people) declined only minimally from 466 in 2000 to
459 in 2010 [2]. Similarly, incidence of MDR-TB among
PTB cases has remained unchanged in the past decade,
and resistance to first-line drugs among newly diagnosed
TB patients rose from 34.2% in 2007/2008 [3] to 36.9%
in 2010 [2].
Limited knowledge about signs and symptoms of TB,
poor health seeking behavior, and poor diagnosis and
disease management in health facilities result in delays
in TB diagnosis and treatment, which in turn, increase
the risk of TB transmission and the development of
MDR-TB [4]. Available evidence shows that only 47% of
Chinese patients with TB symptoms seek healthcare in a
timely fashion and only 59% comply with prescribed
treatment [2].
Early diagnosis and prompt treatment are the core
objectives of an effective national TB control program
[5]. Persons who experience signs and symptoms of TB
should report promptly for diagnosis, and should, if
found to have TB, commence treatment immediately [5].
Unfortunately, this process can be disrupted by delay in
deciding to visit a TB treatment facility [6-8], delay in
obtaining diagnosis [9] and delay in receiving treatment
[10]. These types of delays are reported to be common
in many low- and middle-income countries which have
a high TB burden [8,11-17].
Although reviews conducted on TB care-seeking beha-
vior in sub-Saharan Africa and elsewhere [18,19] suggest
that the epidemiology and control of TB are highly asso-
ciated with socioeconomic and cultural factors, China has
a unique social, economic and cultural context. Thus,
understanding the sociocultural milieu of delays in TB
management in China could help to stem the high burden
of TB in the country. A few studies have been conducted
to explore factors that influence delays in TB care-seeking,
diagnosis and treatment in China. Unfortunately, results
of these studies have been largely inconclusive and incon-
sistent [20-23]. The objective of this review is to critically
summarize available literature on factors that underpin
delays in pulmonary TB care-seeking, and diagnosis in
China. The results could contribute to current efforts to




According to the Chinese Ministry of Health (MOHC)
[24], “patient delay” is defined as a time interval of more
than two weeks between the onset of TB symptoms and
the patient’s first presentation to a health facility. The
Ministry also defines “diagnostic delay” as a time interval
of more than two weeks between a patient’s first visit to
a health facility and the receipt of TB diagnosis.
Search strategy
The review was prepared following standard procedures
of the Cochrane Collaboration [25] and the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement and checklist [26] (see
Additional file 1). To identify eligible studies on factors
associated with TB patient and diagnostic delays pub-
lished up to November 2012, three major databases,
Medline/PubMed, EMBASE and CNKI (China National
Knowledge Infrastructure), were searched. We used a
mixture of free text and index terms to maximize re-
trieval of potentially relevant studies. The following
terms were used for the PubMed search: “pulmonary
tuberculosis and diagnostic delay in China”, “pulmonary
tuberculosis and health system delay in China”, “pul-
monary tuberculosis and detection delay in China”,
“pulmonary tuberculosis and patient delay in China”,
“pulmonary tuberculosis and health provider delay in
China”, “pulmonary tuberculosis and doctor delay in
China”, “pulmonary tuberculosis and identification delay
in China”. Medline subject search terms included: “tu-
berculosis, pulmonary”[Mesh]) AND “diagnosis”[Mesh])
AND “China”[Mesh] or “tuberculosis, pulmonary”[Mesh])
AND “patient acceptance of health care”[Mesh]) AND
“China”[Mesh]. Searches in Medline/Pubmed were limited
to full-text, humans, and English. The search terms used
in EMBASE were ‘lung tuberculosis’/exp AND ‘early diag-
nosis’/exp AND ‘risk factor’/exp, ‘lung tuberculosis’/exp
AND ‘patient’/exp AND ‘delayed diagnosis’/exp, ‘lung
tuberculosis’/exp AND ‘delayed diagnosis’/exp AND ‘risk
factor’/exp, ‘lung tuberculosis’/exp AND ‘patient’/exp
AND ‘patient referral’/exp AND ‘risk factor’/exp, ‘lung
tuberculosis’/exp AND ‘health care facility’/exp AND ‘pa-
tient referral’/exp AND ‘risk factor’/exp. CNKI is a key na-
tional e-publishing project that can be used for searching
articles published in 8,200 Chinese journals. It was utilized
to search for articles in Chinese. The terms and concepts
searched included “patient delay”, “diagnostic delay”, “risk
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factors for patient delay” and “risk factors for diagnostic
delay”. We sought unpublished data from the gray
literature through Google and Google Scholar searches.
We also hand-searched reference lists of identified arti-
cles. Two reviewers (JE and YL) conducted the litera-
ture searches.
Inclusion/exclusion criteria
(1) Types of studies: Case-control, cross-sectional and
cohort studies were included.
(2) Participants: Patients with pulmonary tuberculosis
(including smear positive or negative patients,
newly diagnosed cases and those undergoing
retreatment).
(3) Exposure variables: We collected data on the
following:
(i) Demographic characteristics: marital status
(classified as married or living with partner,
single, widowed, divorced), age (grouped into
60 years and older, and less than 60 years old),
education level (categorized into primary school
and below, middle school and above), residence
(categorized into rural and urban).
(ii) Risk behavior/lifestyle: smoking and alcohol
consumption (categorized into smoker, non-
smoker, alcohol drinker and non-drinker).
(iii) Health systems factors: health facilities
(categorized into non-TB health facilities and
TB health facilities), health resource related to
TB diagnosis, ability of health providers and
traffic or geographical barriers.
(4) Outcomes measures: TB patient delay and TB
diagnosis delay.
When there was evidence of multiple publications of
the same study over time, only the article with a full report
was included. Reports on TB suspects, extra-pulmonary
TB, HIV infected TB patients, qualitative studies (data col-
lected by qualitative research methods) and studies that
focus on PTB patients in Hong Kong, Macao and Taiwan
were excluded.
Study selection
Application of inclusion and exclusion criteria to iden-
tified studies was done by two reviewers (DL and YB).
Both reviewers independently screened titles and ab-
stracts of identified studies to assess their eligibility for
inclusion in the review, using an eligibility form based
on the inclusion criteria. Where there were disagree-
ments regarding eligibility of studies, all reviewers par-
ticipated in the decision about inclusion by discussion
and consensus.
Quality assessment
We assessed the quality of case-control and cohort studies
using the Newcastle-Ottawa Scale [27]. For case-control
studies, we assessed the adequacy of case and control def-
inition, representativeness of the cases, whether controls
were derived from the same population as cases, compar-
ability of cases and controls on the basis of design and
analyses, ascertainment of exposure and non-response
rates. For cohort studies, we assessed representativeness
of the exposed cohort in the study setting, selection of
non-exposed cohort, ascertainment of exposure, evidence
that participants do not have outcome of interest at re-
cruitment into the study, comparability of cohorts on the
basis of design and analyses, outcome assessment and
adequacy of follow-up [27]. After assessing the quality of
each included study on the basis of these criteria, we
assigned a composite quality score ranging from 0 (low)
to 8 (high).
For cross-sectional studies, we used the guideline for
critical appraisal of cross-sectional studies developed by
the National Collaborating Center for Environmental
Health [28], which was adapted from a combination of
items from the Newcastle-Ottawa Scale [27], the Critical
Appraisal Skills Program [29], Critical Appraisals by
Elwood [30], and Aschengrau and Seage III [31]. Specif-
ically, we assessed representativeness of the study partici-
pants, methods for ascertaining exposure; comparability
of exposure groups (including unexposed) in terms of age,
sex, socioeconomic status and response bias; determin-
ation and validation of outcomes; internal validity; and
how confounding factors were assessed and addressed.
After reviewing the quality of each included study on the
basis of these criteria, we assigned a composite quality
score that ranged from 0 (low) to 4 (high). Two reviewers
(YL and JE) assessed study quality and reached a consen-
sus grade for each included study.
Data abstraction
Data from eligible studies were independently abstracted
by two reviewers (BY and KL). Differences were resolved
by consensus among all reviewers. Data extracted from
each study included name of first author, year of publi-
cation, type of study design, place of study, type of
participants (newly diagnosed/retreatment and smear
positive/negative pulmonary TB patients), residence of
participants (rural/urban), sampling size, outcome (pa-
tient delay/diagnostic delay), information used for com-
paring analyses (numbers of participants with/without
exposure variables) and the main results were extracted
for all included studies.
Assessment of heterogeneity
Heterogeneity was evaluated using the Q test [32] and
the I-squared statistic (I2 = 100% × (Q-df )/Q) [33]. For
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the Q test, a P-value of 0.10 or less was considered
statistically significant, indicating marked heterogeneity
among studies. Where the P-value was ≤0.10, we cal-
culated I2, and studies with heterogeneity levels of ≤50%
were deemed acceptable. Where heterogeneity was more
than 50%, we conducted subgroup analysis to explore
possible reasons for the heterogeneity. For subgroup
analyses, the heterogeneity within groups was also tested,
using the same statistical methods.
Data synthesis
The first step of the data analysis involved a qualitative
synthesis aimed at summarizing, comparing and con-
trasting the extracted data. Meta-analyses were then con-
ducted to assess the association among patient delay,
diagnostic delay, and gender, age, education, residence,
healthcare seeking behaviors (TB health facility for first
consultation or seeking care from Traditional Chinese
Medicine (TMC) providers) and lifestyle factors (smoking
and alcohol use). Only studies that adopted the definitions
of patient and diagnostic delays proposed by the Office of
TB Control in the MOHC [24] were included in the quan-
titative meta-analysis. We calculated pooled odds ratio
(OR) separately for each factor, using RevMan 5.2 [25]. As
noted earlier, we used the fixed effect model where the
level of heterogeneity was acceptable (that is, P = >0.10, or
P = ≤0.10, but I2 = ≤50%), and the random effects model
was used where there was significant heterogeneity (that
is, P = ≤0.10, but I2 = >50%). We assessed sources of
heterogeneity by conducting sub-group analyses.
Results
Description of studies
Figure 1 presents an illustration of the search output.
Altogether, the initial search yielded 434 potentially rele-
vant articles. Only 29 studies [14,20-23,34-57] met the cri-
teria for inclusion in the review which involved 38,947
pulmonary TB patients from 17 provinces (Table 1). The
Figure 1 Results of literature search. This figure is a description of the full search process.
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included studies comprised 27 cross-sectional studies, 1
cohort, and 1 case-control study. A majority of the studies
(16 out of 29) included newly diagnosed smear-positive
PTB patients. The studies applied different definitions of
patient and diagnostic delays (Figure 2). However, a ma-
jority (23 of 29 studies) adopted the definitions of MOHC
(Figure 2A). All 29 studies were included in qualitative
data synthesis. However, only 13 cross-sectional studies
[14,20-23,36,38-42,44] with 23,917 TB patients had suffi-
cient data to qualify for inclusion in the meta-analysis.
The quality assessment of studies indicated that eight
cross-sectional studies [14,34,35,46,48-51] had a high
quality score of 4 (out of 4). Eighteen cross-sectional
studies had a score of 3, mainly because they did not
control for confounding factors (Table 2). The cohort
study [52] and case-control study [53] had high quality
scores of 7 and 8, respectively, (out of 8) (Table 3).
Data synthesis
Summary of qualitative findings
Individual level factors Patient’s socio-demographic fac-
tors: Although results on the association between gender,
age and patient, and diagnostic delays were fairly incon-
sistent (Table 1), a majority of the studies reported that
females were more likely than males to experience pa-
tient delay [20,22,42,44] and diagnostic delay [14,35,50].
A majority of the studies (18 of 29) demonstrated that
several indicators of socioeconomic status (low educa-
tional attainment, rural residence, lack of health insur-
ance, low income and inability to afford time off work)
were risk factors for patient and diagnostic delays.
Patient’s healthcare seeking behaviors: Many studies
reported the first visit to non-TB control health facilities,
notably, traditional healer providers, was a risk factor for
diagnostic delay [14,35,36,39,41,50,54].
Patient’s TB knowledge/awareness: Seventeen studies
demonstrated that lack of TB knowledge (symptoms of
TB, transmission mode of TB and TB control facilities)
and poor TB awareness were risk factors for patient
delay (Table 1). Evidence [40] also showed that TB
stigma was associated with patient delay, and diagnostic
delay (OR (95% CI): 14.65 (6.217, 31.78)) [14]. Only one
study [35] analyzed the associations among smoking,
alcohol use and patient/diagnostic delays. This study
demonstrated no significant associations.
Health systems factors Seventeen studies analyzed the
relationship between health facility related factors and
patient/diagnostic delays. It was found [40-42] that limi-
tation in availability of resources to perform prompt
diagnosis (for example, lack of facilities for X-rays and
sputum test at village and township level health facil-
ities) was a risk factor for TB diagnostic delay. Shortage
of trained health providers at TB control facilities (for ex-
ample, county TB dispensary and designated county
hospitals for TB care), and geographical barriers were
important causes of TB diagnostic delay [57], as well as
factors related to the health facility staff (health workers’
inadequate TB knowledge [22,38], inability to prescribe
smear test for TB suspects [23,39,55], inability to refer TB
suspects to county TB dispensaries or designated hospitals
for TB care [21,38,55] and misdiagnosis [45,53,55,57]).
Summary of findings from meta-analysis Patient’s
socio-demographic factors: Results of meta-analysis dem-
onstrated patients living in rural areas (Table 4, Figures 3
and 4) were more likely to have patient delays (pooled
OR (95% CI): 1.79 (1.62, 1.98)) and diagnostic delays
(pooled OR (95% CI): 1.40 (1.23, 1.59)). Subgroup ana-
lysis by gender (Table 4 and Figure 3) showed that fe-
males who lived in rural areas were more likely to delay
seeking healthcare for TB than their male counterparts
(pooled OR (95% CI): 1.94 (1.13, 3.33)). Available data
did not indicate that age was an important factor. Re-
sults of meta-analysis (Table 4 and Figure 3) showed that
patients aged 60 years and older had no higher risk
of patient delay than younger individuals (pooled OR
(95% CI): 1.27 (0.81, 3.63)). As shown in Table 4 and
Figure 3, having low educational attainment (primary
school and below) was a risk factor for patient delays
(pooled OR (95% CI): 2.14 (1.03, 4.47)).
Patient’s healthcare seeking behaviors: Results of meta-
analysis indicated that seeking care first from TMC pro-
viders was a risk factor for diagnostic delay (pooled OR
(95% CI): 5.75 (3.03, 10.94)). (Table 4 and Figure 4).
Discussion
An important epidemiological challenge for TB control
in China is inadequate and late case detection [58]. Un-
derstanding the factors that underpin delays in accessing
TB services as well as delays in receiving prompt diagno-
sis and treatment is central to effective control [5]. In
this review, results of qualitative and quantitative ana-
lyses indicate that patient and diagnostic delays in TB
diagnosis and care are mediated by a constellation of
individual patient factors and health systems factors. As
noted by Glanz et al. [59], individual-level factors
include demographics, knowledge, attitudes, behaviors,
beliefs, perceived barriers, skills, gender, level of educa-
tion, socioeconomic status and so on. Health systems
factors include factors that operate within the health
system that promote or hinder patients’ access and treat-
ment [59]. These include health system financing, health
services delivery, resources and support systems, gover-
nance community inputs and human resources [60]. At
the individual level, results in the review showed that
socio-demographic, mostly economic factors (lack of
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Table 1 Studies included in systematic review and meta-analysis
Studies Type of
study





Zhang 2006 [14] CS Hunan Province New SP PTB Rural 318 DD (>2 weeks) PD: No haemoptysis (OR (95% CI): 0.119 (0.041, 0.344)),
distance to health facility (OR (95% CI): 24.73 (6. 872, 58.
56)), seeking care from traditional medicine providers
(OR (95% CI): 14.39 (4.379, 47.30)), poverty (OR (95% CI):
23.53 (8.389, 65.96))
PD (>2 weeks) DD: Being female (OR (95% CI): 3.06 (1.412, 6.645)), low
education (OR (95% CI): 0.57 (0.370, 0.794)), limited
access to TB education (OR (95% CI): 0.45 (0.218, 0.534)),
seeking care from traditional medicine providers (OR
(95% CI): 2.42 (1.057, 5.536)), seeking prescription from
herbalist (OR (95% CI): 2.53 (1.261, 5.077)), and stigma
(OR (95% CI): 14.65 (6.217, 31.78)).
Xi 2011 [20] CS Shandong
Province
PTB Rural 819 DD (>2 weeks) DD: First consultation with traditional medicine
providers
He 2009 [21] CS Hebei Province New SP PTB migrants from
Rural
168 PD (>2 weeks) PD: Low education level (P <0.05), lack of health
insurance (P <0.01)
Huan 2007 [22] CS Guizhou
Province
New PTB Rural/urban 200 PD (>2 weeks) PD: Distance to health facility;
DD (>2 weeks) DD: Poor equipment in health facility, health worker’s
poor TB awareness and knowledge, poor referral
Wu 2008 [23] CS Anhui Province New SP PTB Rural/urban 148 PD (>2 weeks) PD: Poor TB awareness
DD (>2 weeks) DD: Lack of equipment and qualified health workers in
township hospital.
Wang 2007 [34] CS Shanghai New SP/SN PTB No description 222 PD was defined as
the duration from the
onset of symptoms to
the first visit to a
doctor in a hospital.
PD: Low income level (OR (95% CI): 3.859 (1.040, 14.314)
for Level 1/level 4, 5.369 (1.717, 16.787) for Level 2/level
4), without Haemoptysis (OR (95% CI): 0.347 (0.127, 0.948))
Bai 2004 [35] CS Yunnan Province New/re-treatment
SP/SN PTB
Rural/urban 142 PD (>2 weeks) PD: Being male (P = 0.037), with spouse (P = 0.010), no
hemoptysis (P = 0.035);
DD (>2 weeks) DD: No night swear (P = 0.030) and chest pain
(P = 0.042), respiratory difficulty (P = 0.029), no timely
referring (P = 0.001).




Rural 210 PD (>2 weeks) PD: Female (P = 0. 018), lack of TB knowledge
(P = 0.003), Low access to health facility (P = 0.009)
Yang 2010 [37] CS Hujian, Henan,
Liaoling, Xinjiang
Province
PTB Rural 888 PD (>2 weeks) PD: Being female, the elderly, lack of TB knowledge,
poverty and traffic difficulty
Zhou 2009 [38] CS Henan Province New PTB No description 102 PD (>2 weeks) PD: Poor TB awareness; poverty, traffic difficulty;

















Table 1 Studies included in systematic review and meta-analysis (Continued)
Li 2002 [39] CS Hunan Province New SP PTB Rural/urban 3275 PD (>2 weeks) PD: Being male (P = 0. 003), 30 to 44 years old (P = 0.
009), poor TB awareness, poverty, traffic difficulty;
DD (>2 weeks) DD: 30 to 44 years old (P = 0. 0001), poor TB
knowledge, without smear test in county hospital
Shi 2006 [40] CS Liaolin, Hujian,
Xingjiang, Henan
Province
New SP PTB No description 186 DD (>2 weeks) DD: Consulting traditional medicine providers first, no
resource for TB diagnosis
Yu 2007 [41] CS Anhui Province New SP PTB Rural/urban 17873 PD (>2 weeks) PD: Being female (P <0.05), Rural area;
DD (>2 weeks) DD: Rural and diagnosed in non-TB hospital, no
resource for TB diagnosis
Zhang 2011 [42] CS Jiangsu Province New SP PTB Rural/urban 276 DD (>2 weeks) DD: Consulting with traditional medicine providers first,
no resource for TB diagnosis
Cai 2007 [43] CS Gansu Province New/retreatment
SP/SN PTB
Rural 150 PD (>2 weeks) PD: The elderly, female, low income, and education
level, poor TB knowledge
Chai 2008 [44] CS Henan Province New SP PTB Rural/urban 200 PD (>3 weeks) PD: Poor TB awareness, no severe symptoms, busy with
work and poverty; stigma for the female
DD (>2 weeks) DD: Misdiagnosis, no severe symptoms
Tian 2001 [45] CS Shangdong
Province
PTB, the youth No description 400 PD (>2 weeks) PD: Knowledge of TB control unit and TB awareness
DD (>2 weeks) DD: No haemoptysis (OR (95%): 0.52 (0.27, 0.98)), night
swearing (OR (95%): 0.44 (0.23, 0.85)), chest pain
(OR (95%): 2.15 (1.12, 4.15)).
Yang 2011 [46] CS Jiangsu Province New SP PTB No description 105 PD (>2 weeks) PD: Poor TB awareness, low income level, distance to
health facilities




314 PD (>2 weeks) PD: Busy at with work (working more than 6 days per
week) (OR (95% CI):6. 70 (2. 80, 16.03)), no health
insurance (OR (95% CI): 2.27 (1.07, 4.82)), distance to
health facility (OR(95% CI): 2.13 (0.73, 6.18)), no
hemoptysis (OR(95% CI): 0. 30 (0. 10, 0. 91)),
Geng 2010 [48] CS Shangdong
Province
New SP PTB Rural 200 PD was defined as
the duration from the
onset of cough to the
first visit to any
healthcare provider
PD: Poor TB awareness, low income level, lack of
knowledge of TB control unit (F = 4.39, P <0.01)
Shi 2008 [49] CS Shangdong
Province
New SP TB Rural 312 PD was defined as
the time (in days)
from the onset of
symptoms to first
seeking care at a
health facility
PD: Aged 40 to 59 (Adjusted HR (95% CI):0.34 (0.17,
0.69)), low education (Adjusted HR (95% CI): 1.91 (1.16,
3.14)), distance to health facility (Adjusted HR (95% CI):
1.04 (0.98, 1.11))
DD: Being female (Adjusted HR (95% CI):0.63 (0.43,0.92)),
Consulting with traditional medicine providers first
(Adjusted HR (95% CI):1.14 (0.52, 2.51))
Cheng 2005 [50] CS Shanghai,
Guangdong,
Jiangsu Province
New PTB migrants 323 PD (≥10 days) PD: Busy with work (AOR (95% CI):1.61 (1.03, 2.51)), no

















Table 1 Studies included in systematic review and meta-analysis (Continued)
Li 2012 [51] CS Shanghai,
Guangdong and
Jiangsu
new PTB migrant from rural 323 Patient delay ≥10
days
Average monthly working days ≥24, and without
hemoptysis or bloody sputum
Lin 2008 [52] Cohort Yunnan Province SP TB, Rural 10356 PD (≥60 days) PD: Geographical barrier, age >40, low income level
(Adjusted HR (95%): 0.61 (0.57, 0.65), 0.78 (0.67, 0.90),
0.90 (0.85, 0.94)).
Zhang 2008 [53] CC Jiangsu Province Newly SP PTB
elderly
No description 102 PD (>2 weeks) PD: Poor Tb awareness
DD (>2 weeks) DD: Misdiagnosis
Hou 2001 [54] CS Hubei Province New SP PTB No description 823 PD (>2 weeks) PD: Poor TB awareness, and low income level
DD (>2 weeks) DD: Consulting with traditional medicine providers first
Liu 2000 [55] CS Hunan Province SP PTB, Rural/urban 290 PD (>2 weeks) PD: Poor TB awareness and knowledge;
DD (>2 weeks) DD: Misdiagnosis, poor referral, not prescribing smear
test
Li 2010 [56] CS Shandong
Province
PTB, elderly Rural/urban 322 PD (>2 weeks) PD: 61 to 65 years old and lower income level
Lian 2003 [57] CS Guangzhou
Province
Newly SP PTB No description 117 PD (>2 weeks) PD: Poor TB awareness, low income level, busy with
work, traffic barrier.
DD (>2 weeks) DD: Consulting with traditional medicine providers first
Notes:
CS refers to cross-sectional study and CC refers to case-control study. SP refers to smear positive and SN refers to smear negative. PTB refers to pulmonary tuberculosis.

















health insurance), rural residence, gender, seeing a TMC
provider, educational level and low knowledge of TB are
important determinants of patient delay.
The review showed that rural residence was an im-
portant determinant of patient delay in seeking and
receiving care for TB. It is estimated that a third of TB
suspects in China’s rural settings do not seek care after
three weeks of persistent cough, and lower-income indi-
viduals are less likely to seek care for TB than higher-
income individuals [61]. Programs such as DOTS have
proven successful in detecting and treating TB infection
in China. However, concerns have been raised regarding
the impact of such programs on the most vulnerable
members of the populations, particularly the rural poor
[61]. In spite of the progress made by TB control pro-
grams, “the prevalence of active PTB in rural China, par-
ticularly the Western region, has in fact, increased” [62].
Thus, greater focus on equitable distribution of TB-
related resources and improved targeting of vulnerable
rural populations is of central importance in the control
of TB [61].
The review highlighted the practice of seeing a TMC
provider as a cultural factor that underpins patient de-
lays in seeking and receiving TB diagnosis and treat-
ment. Many Chinese TB patients would have visited a
TCM provider for their ill-health before seeking care at
a formal TB health facility [63]. One potential problem
with seeking a traditional provider prior to attending a
TB diagnosis and treatment facility is that it results in
diagnostic and treatment delays [64]. TCM providers
have been shown to recommend Western antibiotics
along with traditional healing methods, and generally do
not question the effectiveness of Western medicine [63].
Training them to identify early signs and symptoms and
prompt referral of suspected cases to TB diagnosis and
treatment centers is important. Their propensity to refer
cases can be enhanced through an incentive mechanism
that rewards them per positive TB case referred to a TB
diagnosis and treatment center.
Another cultural aspect of TB diagnosis and treatment
delay is the stigma that is attached to the disease, which
drives individuals to hide their condition from others,
thus hindering them from accessing available diagnosis
and treatment services. One study which focused on
public awareness about TB concluded that approxi-
mately 72% of respondents held some stigmatizing atti-
tudes towards the disease. Increasing public knowledge
and awareness of TB as a disease that can be diagnosed
and successfully treated if detected early is important for
TB control efforts in the country [65]. Available evidence
shows that interventions to reduce the TB stigma can be
effective if designed to empower individuals with TB to
resist stigmatizing judgments, while working to change
norms about the disease [66].
Figure 2 This figure presents different definitions of delays used in studies on patient delay and diagnostic delay in mainland China.
A: Patient delay refers to the time from the onset of TB symptoms to first visit to health facility is greater than 2 weeks. Diagnostic delay refers to
the time from the first visit to health facility to TB diagnosis is greater than 2 weeks. B: Patient delay refers to the time from the onset of TB
symptoms to first visit to health facility is greater than 21days. Diagnostic delay refers to the time from the first visit to health facility to TB
diagnosis is greater than 2 weeks. C: Patient delay refers to defined as the duration from the onset of symptoms to the first visit to a doctor in a
hospital. Doctor’s delay was defined as the duration from the first hospital visit to a confirmed TB diagnosis in the designated DTC or designated
TB Care Unit. D: Patient delay was defined as the time (in days) from the onset of symptoms to first seeking care at a health facility. Health
system delay as the time (in days) from first seeking care at a health facility (including village clinics) to diagnosis. E: Delayed initial health-seeking
was defined as duration in excess of the median duration (10 days) (including hospital, TB dispensary, clinic, health center, etc.). F: Patient delay is
defined as the time from the onset of TB symptoms to the first contact with a doctor in a county (or higher) TB center/ hospital.
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Finally, health system financing was been shown to be
an important health systems determinant of patient delay
in seeking TB care. Although the number of people living
below the poverty line in China continues to decline as
the economy grows, gross inequity, particularly in the
financing of health, remains, as there is still significant dif-
ference in terms of socioeconomic development between
the Western and Eastern part of China. The innovative,
pre-market economy Chinese health system of the 1950s
to 1970s has since disintegrated [67]. In an effort to con-
trol the TB epidemic, China has instituted a policy of free
diagnosis and anti-TB drug treatment. In spite of this pol-
icy, all income groups still have to pay out-of-pocket for
the services that are included in a free TB care package,
such as a liver protection drug, CT scan exams, and so on,
and costs are usually high [68]. This is largely a result of
the marketization of healthcare services as a result of eco-
nomic reform launched in the 1980s in China [69]. Access
to medication can be lower and initial access to care may
be delayed as a result of financial barriers [70,71].
To counter the impact of financial barriers on TB care,
many TB programs began to incorporate material and
financial performance-based incentives for patients, and
occasionally, providers in the 1990s. Evaluation studies
of these incentive programs show that they can be ef-
fective in reducing diagnostic and treatment barriers and
delays [72]. Supported with funding from the World
Bank, China experimented with an incentive-based ap-
proach in the 1990s called the Convergence Manage-
ment System under the National TB program of the
MOHC, whereby the program provided free or subsi-
dized TB diagnosis (including sputum tests and chest
X-rays) and treatment (first line anti-TB drugs) to infec-
tious TB patients diagnosed and treated in County TB
Dispensaries (CTD) [73]. Under the Convergence Man-
agement System a bonus was paid to doctors in general
hospitals that referred suspected TB patients to the CTD.
Unfortunately, the full potential of this approach could
not be reached because the referral bonus was only avail-
able to hospital doctors, and not village doctors. A rethink
Table 3 Quality assessment of cohort and case-control studies*
Studies Study design A B C Total score
A1 A2 A3 A4 B1 B2 C1 C2 C3
Lin 2008 [52] Cohort 1 1 1 1 1 — 1 1 0 7
Zhang 2008 [53] CC 1 1 1 1 1 0 1 1 1 8
*Notes:
For cohort studies: A. selection of the study groups (A1 indicates exposed cohort truly representative, non-exposed cohort drawn from the same community, A3
right method for ascertainment of exposure, A4 outcome of interest not present at start the representativeness of controls); B. cohorts comparable (B1 control of
HIV risk factors except IPV, B2 control of any additional factor); C. outcome measurement (C1 quality of outcome assessment, C2, follow-up long enough for
outcomes to occur, C3 complete accounting for cohorts).
For case-control studies: A. selection of the study groups (A1 right case definition, A2 right controls definition, A3 the representativeness of the cases, A4 the
representativeness of controls); B. comparability of the groups (B1 control of main confounders, B2 control of any additional factor); C. ascertainment of the
exposure (C1 appropriate method of exposure ascertainment, C2 same method of exposure ascertainment for cases and controls, C3 same non-response rate of
case and control groups).
1 indicates the study met the criteria; 0 indicates the study did not meet the criteria; A dash indicates fulfillment of the criteria could not be determined.
Table 2 Quality assessment of the cross-sectional studies
included in systematic review and meta-analysis※
Studies Type of study A B C D Total score
Zhang 2006 [14] CS 1 1 1 1 4
Xi 2011 [20] CS 1 1 0 1 3
He 2009 [21] CS 1 1 0 1 3
Huan 2007 [22] CS 1 1 0 1 3
Wu 2008 [23] CS 1 1 0 1 3
Wang 2007 [34] CS 1 1 1 1 4
Bai 2004 [35] CS 1 1 1 1 4
Liao 2009 [36] CS 1 1 0 1 3
Yang 2010 [37] CS 1 1 0 1 3
Zhou 2009 [38] CS 1 1 0 1 3
Li 2002 [39] CS 1 1 0 1 3
Shi 2006 [40] CS 1 1 0 1 3
Yu 2007 [41] CS 1 1 0 1 3
Zhang 2011 [42] CS 1 1 0 1 3
Cai 2007 [43] CS 1 1 0 1 3
Chai 2008 [44] CS 1 1 0 1 3
Tian 2001 [45] CS 1 1 0 1 3
Yang 2011 [46] CS 1 1 1 1 4
Cao 2002 [47] CS 1 1 0 1 3
Geng 2010 [48] CS 1 1 1 1 4
Shi 2008 [49] CS 1 1 1 1 4
Cheng 2005 [50] CS 1 1 1 1 4
Li 2012 [51] CS 1 1 1 1 4
Hou 2001 [54] CS 1 1 0 1 3
Liu 2000 [55] CS 1 1 0 1 3
Li 2010 [56] CS 1 1 0 1 3
Lian 2003 [57] CS 1 1 0 1 3
CC refers to case-control study; CS refers to cross-sectional study. ※
A. representativeness of study participants, B. proper methods to ascertain
exposure, C. comparability of comparing analysis groups and D. lower
non-response bias.
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of the contribution of the incentive-based approach to TB
management in China is warranted given the enormity of
the TB burden in the country.
Similarly, China’s once successful Cooperative Medical
System (CMS) in the rural areas collapsed in the early
1980s leaving the majority of rural dwellers uninsured.
The situation did not improve until 2003 when the
Chinese government started to re-establish New Rural
Cooperative Medical Scheme (NRCMS) [64]. The NRCMS
covered over 90% of the rural population in China by
2011. In addition, the government also started to establish
Urban Resident Basic Health Insurance (URBMI) covering
children and urban residents not covered by Urban
Employee Basic Health Insurance [74]. However, both





Variance between studies Pooled
OR





Gender (Female) 7 32,114 <0.00001 83 1.20 (0.90, 1.62) 0.22
Gender (Female) in rural 3 1,689 0.08 60 1.94 (1.13, 3.33) 0.02
Gender (Female) in urban 4 30,425 0.0004 84 0.91 (0.65, 1.27) 0.59
Severe symptoms 3 940 0.78 0 0.46 (0.32, 0.68) <0.0001
Education 2 575 0.49 0 2.14 (1.03, 4.47) 0.04
Residence in rural 2 24,363 0.91 0 1.79 (1.62, 1.98) <0.0001
Age (≥60 years old) 3 6,941 0.009 79 1.06 (0.69, 1.63) 0. 78
Age (≥60 years old) in rural 2 1,388 0.41 0 1.27 (0.95, 1.70) 0.10
Diagnostic delay
Gender (Female) 3 21,177 0.06 64 1.00 (0.83, 1.22) 0.96
Residence in rural 2 15,809 0.04 76 1.40 (1.23, 1.59) <0.0001
Facility to visit firstly in unorthodox,
non-TB control health facility
3 1,317 0.16 45 5.75 (3.03, 10.94) <0.0001
Figure 3 Forest plots of meta-analysis of factors associated with patient delay. This figure shows forest plots for the meta-analysis of
factors associated with patient delay. OR and 99% CI for each factor are given.
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URBMI and NRCMS do not offer a generous service pack-
age (for example, only inpatient services are covered in
most places of China, and they do not provide a high level
of financial protection since both deductible and co-
payments are high). In spite of this increasing coverage,
out-of-pocket medical care costs remain a significant ex-
pense, particularly for rural residents. More recently, the
free treatment policy has been extended to smear negative
patients [75] and the government also provides transporta-
tion and nutrition subsidies for low income TB patients
[76]. These notwithstanding, patients still make significant
amounts of out-of-pocket payments for the total cost of
their treatment. Approximately 40% of healthcare costs are
paid out-of-pocket by individuals as a result of deductibles
and other expenses. Overall, cost continues to present a
major barrier against diagnosis and treatment of TB in the
rural communities of China with significant implications
for inequity in TB control in the country. Considering the
high burden of TB in the country, it is unlikely that the
government will be able to provide completely free treat-
ment for all TB cases in the foreseeable future, given the
huge financial consequences and the reductions in inter-
national donor support for TB control efforts [77].
Limitations
This review did not identify randomized controlled tri-
als, which was expected since experiments that expose
people of diverse backgrounds to TB in order to assess
how they seek diagnosis and treatment would be un-
ethical. Consequently, the review included mostly cross-
sectional, one case-control and one cohort study. These
studies have a number of inherent limitations that have
the potential to introduce bias in the results of this re-
view. For example, the included cross-sectional studies
had low comparability and were fraught with numerous
confounders. Although the studies controlled for these
confounders using logistic regressions, their residual
effect might have introduced some degree of bias to
the review.
Most of the available studies had different defi-
nitions of patient and diagnostic delays, as well as
multiple classification of socio-demographic variables,
including age, income, education and type of health
facility consulted by TB patients. This limits compar-
ability of the studies, and makes pooled analyses of
results difficult. The meta-analysis was restricted to
studies that adopted the definition of patient delay
proposed by the Office of TB Control in the MOHC
(that is, a time interval of more than two weeks be-
tween the onset of TB symptoms and the patient’s
first presentation to a health facility). We acknow-
ledge the limitation in accurately determining actual
onset of TB symptoms by patients, given the generally
low knowledge of TB among the public [2].
Figure 4 Forest plots of meta-analysis of factors associated with diagnostic delay. This figure shows forest plots for the meta-analysis of
factors associated with diagnostic delay. OR and 99% CI for each factor are given.
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Implications for policy and practice
As findings of this review show, rural residence is an
important determinant of delay in seeking diagnosis by
TB patients in China. At a time when there is global
emphasis on the use of community health workers for
health promotion and disease prevention at the com-
munity level, the need to resurrect the use of health
workers at village and township levels to fight TB in rural
China cannot be over-emphasized [67]. They are well-
placed to provide individualized and community-based
education and promotion to dispel ignorance and to chal-
lenge TB stigma. They can also be effective in referring
suspected cases to appropriate sources of diagnosis and
treatment, and can serve as key liaisons between commu-
nities and the national TB control program.
To address the negative impact of high out-of-pocket
payments, it is important to integrate TB control efforts
into the overall health system, especially health insurance
schemes. The National TB Program (NTP) in China has
recently started to work with the Ministry of Civil Affairs
that is responsible for medical financing assistance for the
poor to ensure that TB patients, particularly MDR-TB pa-
tients, can be diagnosed in a timely fashion and treated
successfully, regardless of their ability to pay [64]. It is also
important for the China CDC to develop measures to en-
sure that clinical guidelines for TB diagnosis and case
management are effectively implemented not only in TB
dispensaries and TB-designated hospitals, but also in the
general hospitals of China. Training of health workers in
effective implementation of established guidelines for TB
diagnosis and treatment should also be seen as an import-
ant component of the arsenal available for addressing the
high burden of TB in China, as is the development of
monitoring and evaluation systems to assess the perform-
ance of these service providers.
Conclusion
An important challenge for TB control in China is inad-
equate and late case detection. Patient and diagnostic delays
in TB care are mediated by individual and health facility
factors. Population-based interventions that seek to reduce
TB stigma and raise awareness about the benefits of early
diagnosis and prompt treatment are needed. Policies that
remove patients’ financial barriers in access to TB care, and
integration of the informal care sector into TB control in
urban and rural settings are central factors in TB control.
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